Are You a Synopsys Investor Who Feels Misled? Here’s What You Need to Know Before It’s Too Late.
New York, NY, November 9, 2025 – Imagine discovering that a company you invested in wasn’t entirely transparent about its financial health. That’s the situation many Synopsys, Inc. (NASDAQ: SNPS) investors find themselves in, according to a recent class action lawsuit. But here’s where it gets controversial: Did Synopsys’ shift toward artificial intelligence clients actually harm its bottom line more than the company let on? And this is the part most people miss—you could be entitled to compensation without paying any upfront fees.
What’s Happening?
Rosen Law Firm, a globally recognized leader in investor rights, has filed a class action lawsuit on behalf of those who purchased Synopsys securities between December 4, 2024, and September 9, 2025. The lawsuit alleges that Synopsys made misleading statements and failed to disclose critical issues about its business operations. Specifically, the company’s increased focus on AI customers—which require more customization—may have negatively impacted its Design IP business more than investors were led to believe. Bold claim? Perhaps. But the lawsuit argues that these omissions had a material impact on financial results, potentially misleading investors.
Why Should You Care?
If you bought Synopsys securities during this period, you might be eligible for compensation. Here’s the catch: You must act by December 30, 2025, to serve as a lead plaintiff. This role allows you to represent other investors in directing the litigation. Don’t worry—you won’t pay any out-of-pocket fees, as the case operates on a contingency basis.
What’s Next?
To join the class action, visit Rosen Law Firm’s case submission page or contact Phillip Kim, Esq., toll-free at 866-767-3653 or via email at case@rosenlegal.com. But here’s the controversial part: Not all law firms are created equal. Rosen Law Firm stands out with a proven track record, including the largest-ever securities class action settlement against a Chinese company. Yet, some might argue that not every investor needs to join a class action. What’s your take? Is this lawsuit justified, or is it an overreaction?
The Details Matter
The lawsuit claims Synopsys failed to disclose four key issues: (1) the extent to which AI customer demands were hurting its Design IP business, (2) that certain strategic decisions were unlikely to succeed, (3) the negative financial impact of these issues, and (4) that positive statements about the company’s prospects lacked a reasonable basis. When the truth emerged, investors allegedly suffered losses.
Important Notes
No class has been certified yet, so you’re not represented unless you retain counsel. You can choose your own attorney or remain an absent class member. Either way, your ability to share in any recovery doesn’t depend on being a lead plaintiff.
Stay Informed
Follow Rosen Law Firm for updates on LinkedIn, Twitter, or Facebook.
Disclaimer
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information
Laurence Rosen, Esq. | Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor, New York, NY 10016
Tel: (212) 686-1060 | Toll Free: (866) 767-3653
Fax: (212) 202-3827 | Email: case@rosenlegal.com
Website: www.rosenlegal.com
Final Thought: Is this lawsuit a wake-up call for investors to scrutinize companies’ AI strategies more closely? Or is it an overreach? Share your thoughts in the comments—we want to hear from you!
